OVID logo

Ovid Therapeutics (OVID) EBITDA

Annual EBITDA

-$57.69 M
-$3.52 M-6.50%

December 31, 2023

Summary

Performance

1-Year Change

-6.5%

3-Year Change

+28.89%

5-Year Change

-9.27%

15-Year Change

+11.15%

OVID EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.77%
OVID annual EBITDA is higher than 29.77% of companies in Healthcare sector

High & Low

All-time High

$124.45 M
OVID annual EBITDA is currently -146.35% below its historical high of $124.45 million

3-Year Low

-$57.69 M
OVID annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OVID previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
OVID next annual earnings announcement is scheduled for Mar 7, 2025

OtherOVIDprofitabilitymetrics:

Annual Revenue

$391.70 K
OVID annual revenue is $391.70 thousand

Annual Net Income

-$52.34 M
OVID annual net profit is -$52.34 million

Annual EBIT

-$59.28 M
OVID annual earnings before interest & taxes is -$59.28 million

Annual EPS

-$0.74
OVID annual earnings per share is -$0.74

Quarterly EBITDA

-$13.06 M
+$7.46 M+36.36%

September 30, 2024

Summary

Performance

3-Month Change

+36.36%

1-Year Change

+23.29%

3-Year Change

+23.29%

5-Year Change

+23.29%

OVID Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.56%
OVID quarterly EBITDA is higher than 30.56% of companies in Healthcare sector

High & Low

All-time High

$176.63 M
OVID quarterly EBITDA is currently -107.39% below its historical high of $176.63 million

3-Year Low

-$26.30 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDprofitabilitymetrics:

Quarterly Revenue

$173.00 K
OVID quarterly revenue is $173.00 thousand

Quarterly Net Income

-$14.01 M
OVID quarterly net profit is -$14.01 million

Quarterly EBIT

-$13.23 M
OVID quarterly earnings before interest & taxes is -$13.23 million

Quarterly EPS

-$0.20
OVID quarterly earnings per share is -$0.20

TTM EBITDA

-$67.61 M
-$1.17 M-1.77%

September 30, 2024

Summary

Performance

3-Month Change

-1.77%

1-Year Change

-17.44%

3-Year Change

-17.44%

5-Year Change

-17.44%

OVID TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.03%
OVID TTM EBITDA is higher than 26.03% of companies in Healthcare sector

High & Low

All-time High

$129.23 M
OVID TTM EBITDA is currently -152.32% below its historical high of $129.23 million

3-Year Low

-$68.73 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDprofitabilitymetrics:

TTM Revenue

$631.70 K
OVID TTM revenue is $631.70 thousand

TTM Net Income

-$32.50 M
OVID TTM net profit is -$32.50 million

TTM EBIT

-$69.35 M
OVID TTM earnings before interest & taxes is -$69.35 million

TTM EPS

-$0.47
OVID TTM earnings per share is -$0.47

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$57.69 M
OVID annual EBITDA is -$57.69 million

Annual Net Income

-$52.34 M
OVID annual net profit is -$52.34 million

Annual Interest Expense

-
OVID annual interest expense value is unknown

Annual Income Tax

$0.00
OVID annual income tax is $0.00

Annual D&A

$1.60 M
OVID annual depreciation & amortization is $1.60 million

OVID EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.5%+23.3%-17.4%
3 y3 years+28.9%+23.3%-17.4%
5 y5 years-9.3%+23.3%-17.4%

OVID EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-146.3%at low-11.3%+50.4%-154.3%+1.6%
5 y5-year-146.3%+28.9%-107.4%+50.4%-152.3%+16.7%
alltimeall time-146.3%+28.9%-107.4%+61.9%-152.3%+16.7%

Ovid Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.06 M(-36.4%)
-$67.61 M(+1.8%)
Jun 2024
-
-$20.52 M(+20.6%)
-$66.44 M(+10.6%)
Mar 2024
-
-$17.02 M(-0.0%)
-$60.09 M(+4.4%)
Dec 2023
-$57.69 M(+6.5%)
-$17.02 M(+43.2%)
-$57.57 M(+10.1%)
Sep 2023
-
-$11.88 M(-16.2%)
-$52.28 M(-1.0%)
Jun 2023
-
-$14.17 M(-2.2%)
-$52.79 M(+0.6%)
Mar 2023
-
-$14.49 M(+23.5%)
-$52.47 M(-3.1%)
Dec 2022
-$54.17 M(-143.5%)
-$11.73 M(-5.3%)
-$54.17 M(-21.2%)
Sep 2022
-
-$12.39 M(-10.6%)
-$68.73 M(+1.1%)
Jun 2022
-
-$13.85 M(-14.5%)
-$67.97 M(-0.6%)
Mar 2022
-
-$16.19 M(-38.4%)
-$68.38 M(-154.9%)
Dec 2021
$124.45 M(-253.4%)
-$26.30 M(+126.1%)
$124.45 M(-3.7%)
Sep 2021
-
-$11.63 M(-18.5%)
$129.23 M(+3.8%)
Jun 2021
-
-$14.26 M(-108.1%)
$124.54 M(+7.6%)
Mar 2021
-
$176.63 M(-921.2%)
$115.74 M(-242.7%)
Dec 2020
-$81.12 M
-$21.51 M(+31.8%)
-$81.12 M(+5.6%)
Sep 2020
-
-$16.32 M(-29.2%)
-$76.83 M(-0.5%)
Jun 2020
-
-$23.06 M(+14.0%)
-$77.22 M(+14.6%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$20.23 M(+17.5%)
-$67.41 M(+10.2%)
Dec 2019
-$61.15 M(+15.8%)
-$17.21 M(+3.0%)
-$61.15 M(+7.3%)
Sep 2019
-
-$16.71 M(+26.1%)
-$57.01 M(+6.7%)
Jun 2019
-
-$13.25 M(-5.2%)
-$53.44 M(+0.1%)
Mar 2019
-
-$13.98 M(+6.9%)
-$53.37 M(+1.1%)
Dec 2018
-$52.79 M(-18.7%)
-$13.07 M(-0.5%)
-$52.80 M(+4.0%)
Sep 2018
-
-$13.14 M(-0.3%)
-$50.75 M(+8.0%)
Jun 2018
-
-$13.18 M(-1.6%)
-$47.00 M(+6.6%)
Mar 2018
-
-$13.40 M(+21.6%)
-$44.09 M(-32.1%)
Dec 2017
-$64.93 M(+188.8%)
-$11.03 M(+17.4%)
-$64.93 M(+5.6%)
Sep 2017
-
-$9.39 M(-8.6%)
-$61.46 M(+6.2%)
Jun 2017
-
-$10.27 M(-70.0%)
-$57.87 M(+9.2%)
Mar 2017
-
-$34.24 M(+353.2%)
-$53.01 M(+135.8%)
Dec 2016
-$22.48 M(+70.6%)
-$7.56 M(+30.1%)
-$22.48 M(+50.6%)
Sep 2016
-
-$5.81 M(+7.4%)
-$14.92 M(+63.7%)
Jun 2016
-
-$5.41 M(+45.8%)
-$9.12 M(+145.8%)
Mar 2016
-
-$3.71 M
-$3.71 M
Dec 2015
-$13.18 M
-
-

FAQ

  • What is Ovid Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Ovid Therapeutics?
  • What is Ovid Therapeutics annual EBITDA year-on-year change?
  • What is Ovid Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Ovid Therapeutics?
  • What is Ovid Therapeutics quarterly EBITDA year-on-year change?
  • What is Ovid Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Ovid Therapeutics?
  • What is Ovid Therapeutics TTM EBITDA year-on-year change?

What is Ovid Therapeutics annual EBITDA?

The current annual EBITDA of OVID is -$57.69 M

What is the all time high annual EBITDA for Ovid Therapeutics?

Ovid Therapeutics all-time high annual EBITDA is $124.45 M

What is Ovid Therapeutics annual EBITDA year-on-year change?

Over the past year, OVID annual EBITDA has changed by -$3.52 M (-6.50%)

What is Ovid Therapeutics quarterly EBITDA?

The current quarterly EBITDA of OVID is -$13.06 M

What is the all time high quarterly EBITDA for Ovid Therapeutics?

Ovid Therapeutics all-time high quarterly EBITDA is $176.63 M

What is Ovid Therapeutics quarterly EBITDA year-on-year change?

Over the past year, OVID quarterly EBITDA has changed by +$3.96 M (+23.29%)

What is Ovid Therapeutics TTM EBITDA?

The current TTM EBITDA of OVID is -$67.61 M

What is the all time high TTM EBITDA for Ovid Therapeutics?

Ovid Therapeutics all-time high TTM EBITDA is $129.23 M

What is Ovid Therapeutics TTM EBITDA year-on-year change?

Over the past year, OVID TTM EBITDA has changed by -$10.04 M (-17.44%)